FdaApplication
NDA 218145
Identifiers
- fda_app_no: NDA218145
Properties
| Property | Value |
|---|---|
| applicant_name | OTSUKA PHARMACEUTICAL CO LTD |
| application_type | NDA |
Products (1)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| SIMTRIYO | CENTANAFADINE HYDROCHLORIDE | 280MG | CAPSULE, EXTENDED RELEASE |
1 product